Joint Formulary & PAD

Ranolazine - Angina

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Modified release tablets
Associated Icons :
Restrictions / Comments :
Important
Restricted to cardiology

PAD Profile

ChemicalSubstance :
Ranolazine
Indication :
Angina
Group Name :
Keywords :
Brand Names Include :
Ranexa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Ranolazine is used to treat.

  • No records returned.

Committee Recommendations (1)

A scheduled review of the expired Amber Shared Care document has taken place and was approved at PCN. The place in therapy of Ranolazine for stable Angina had previously been discussed by the PCN in March 2012 and the policy statement from those discussions still stands. See below for approved AMBER Shared Care and policy statement (PCN 13-2012) from previous discussions.